These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 31934812)

  • 1. Effects of the Selective EP2 Receptor Agonist Omidenepag on Adipocyte Differentiation in 3T3-L1 Cells.
    Yamamoto Y; Taniguchi T; Inazumi T; Iwamura R; Yoneda K; Odani-Kawabata N; Matsugi T; Sugimoto Y; Shams NK
    J Ocul Pharmacol Ther; 2020 Apr; 36(3):162-169. PubMed ID: 31934812
    [No Abstract]   [Full Text] [Related]  

  • 2. Addition of EP2 agonists to an FP agonist additively and synergistically modulates adipogenesis and the physical properties of 3D 3T3-L1 sphenoids.
    Ida Y; Watanabe M; Umetsu A; Ohguro H; Hikage F
    Prostaglandins Leukot Essent Fatty Acids; 2021 Aug; 171():102315. PubMed ID: 34246925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omidenepag, a non-prostanoid EP2 receptor agonist, induces enlargement of the 3D organoid of 3T3-L1 cells.
    Ida Y; Hikage F; Umetsu A; Ida H; Ohguro H
    Sci Rep; 2020 Sep; 10(1):16018. PubMed ID: 32994409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous Use of ROCK Inhibitors and EP2 Agonists Induces Unexpected Effects on Adipogenesis and the Physical Properties of 3T3-L1 Preadipocytes.
    Ida Y; Watanabe M; Ohguro H; Hikage F
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the prostanoid FP receptor inhibits adipogenesis leading to deepening of the upper eyelid sulcus in prostaglandin-associated periorbitopathy.
    Taketani Y; Yamagishi R; Fujishiro T; Igarashi M; Sakata R; Aihara M
    Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1269-76. PubMed ID: 24508785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of selective EP2 receptor agonist, omidenepag, on trabecular meshwork cells, Schlemm's canal endothelial cells and ciliary muscle contraction.
    Nakamura N; Honjo M; Yamagishi R; Igarashi N; Sakata R; Aihara M
    Sci Rep; 2021 Aug; 11(1):16257. PubMed ID: 34376747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycine enhances expression of adiponectin and IL-10 in 3T3-L1 adipocytes without affecting adipogenesis and lipolysis.
    Chen J; Ma X; Yang Y; Dai Z; Wu Z; Wu G
    Amino Acids; 2018 May; 50(5):629-640. PubMed ID: 29356901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro study of antiadipogenic profile of latanoprost, travoprost, bimatoprost, and tafluprost in human orbital preadiopocytes.
    Choi HY; Lee JE; Lee JW; Park HJ; Lee JE; Jung JH
    J Ocul Pharmacol Ther; 2012 Apr; 28(2):146-52. PubMed ID: 22107041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretreatment of cultured preadipocytes with arachidonic acid during the differentiation phase without a cAMP-elevating agent enhances fat storage after the maturation phase.
    Khan F; Syeda PK; Nartey MN; Rahman MS; Islam MS; Nishimura K; Jisaka M; Shono F; Yokota K
    Prostaglandins Other Lipid Mediat; 2016 Mar; 123():16-27. PubMed ID: 26928048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin F2α and EP2 agonists, and a ROCK inhibitor modulate the formation of 3D organoids of Grave's orbitopathy related human orbital fibroblasts.
    Ichioka H; Ida Y; Watanabe M; Ohguro H; Hikage F
    Exp Eye Res; 2021 Apr; 205():108489. PubMed ID: 33587909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic Characterization of Omidenepag Isopropyl, a Novel Selective EP2 Receptor Agonist, as an Ocular Hypotensive Agent.
    Kirihara T; Taniguchi T; Yamamura K; Iwamura R; Yoneda K; Odani-Kawabata N; Shimazaki A; Matsugi T; Shams N; Zhang JZ
    Invest Ophthalmol Vis Sci; 2018 Jan; 59(1):145-153. PubMed ID: 29332128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-Oleoyl glycine, a lipoamino acid, stimulates adipogenesis associated with activation of CB1 receptor and Akt signaling pathway in 3T3-L1 adipocyte.
    Wang S; Xu Q; Shu G; Wang L; Gao P; Xi Q; Zhang Y; Jiang Q; Zhu X
    Biochem Biophys Res Commun; 2015 Oct; 466(3):438-43. PubMed ID: 26365347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 6-gingerol inhibits rosiglitazone-induced adipogenesis in 3T3-L1 adipocytes.
    Tzeng TF; Chang CJ; Liu IM
    Phytother Res; 2014 Feb; 28(2):187-92. PubMed ID: 23519881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of prostaglandin F(2α) on adipocyte biology relevant to graves' orbitopathy.
    Draman MS; Grennan-Jones F; Zhang L; Taylor PN; Tun TK; McDermott J; Moriarty P; Morris D; Lane C; Sreenan S; Dayan C; Ludgate M
    Thyroid; 2013 Dec; 23(12):1600-8. PubMed ID: 24001049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D decreases adipocyte lipid storage and increases NAD-SIRT1 pathway in 3T3-L1 adipocytes.
    Chang E; Kim Y
    Nutrition; 2016 Jun; 32(6):702-8. PubMed ID: 26899162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactivities of a Prostanoid EP2 Agonist, Omidenepag, Are Useful for Distinguishing between 3D Spheroids of Human Orbital Fibroblasts without or with Graves' Orbitopathy.
    Ida Y; Ichioka H; Furuhashi M; Hikage F; Watanabe M; Umetsu A; Ohguro H
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of leucine on adipogenesis in 3T3-L1 preadipocytes during and after differentiation].
    Yang JT; Xu JY; Jiao J; Zhang R; Han SF; Qin LQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Jun; 50(6):535-40. PubMed ID: 27256735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin F2 and EP2 Agonists Exert Different Effects on 3D 3T3-L1 Spheroids during Their Culture Phase.
    Ida Y; Furuhashi M; Watanabe M; Umetsu A; Hikage F; Ohguro H
    Biomedicines; 2021 Dec; 9(12):. PubMed ID: 34944637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics, Safety, and Intraocular Pressure-Lowering Profile of Omidenepag Isopropyl, a Selective, Nonprostaglandin, Prostanoid EP2 Receptor Agonist, in Healthy Japanese and Caucasian Volunteers (Phase I Study).
    Aihara M; Lu F; Kawata H; Tanaka Y; Yamamura K; Odani-Kawabata N; Shams NK
    J Ocul Pharmacol Ther; 2019 Dec; 35(10):542-550. PubMed ID: 31674861
    [No Abstract]   [Full Text] [Related]  

  • 20. Suppression of adipocyte differentiation and lipid accumulation by stearidonic acid (SDA) in 3T3-L1 cells.
    Li Y; Rong Y; Bao L; Nie B; Ren G; Zheng C; Amin R; Arnold RD; Jeganathan RB; Huggins KW
    Lipids Health Dis; 2017 Sep; 16(1):181. PubMed ID: 28946872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.